Registry for children with PTEN Hamartoma Tumor Syndrome
Part of Bones, joints & muscles, Brain & nervous system, Cancer, Genetic & congenital, Mental health clinical trials.
This study is creating a registry (a database) of children with PTEN Hamartoma Tumor Syndrome, a condition that can cause growths, large head size, and other health issues. By joining, you help doctors learn more about the condition and how to better care for kids like yours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have a diagnosis or strong suspicion of PTEN Hamartoma Tumor Syndrome (PHTS).
- There must be a change (mutation) in the PTEN gene from a genetic test, even if the meaning of that change is not yet fully known.
- You or your child must have some of the physical signs or symptoms of PHTS, like a large head size, skin growths, or developmental delays.
- You must agree to join the study and share medical information.
- You cannot join if you do not have a PTEN gene mutation and do not have any PHTS symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children and their affected relatives who have a harmful change in the PTEN gene. The goal is to understand the health risks, especially the chance of developing cancer, over time.
This study is an international registry (a way to collect medical information) for people with certain rare brain tumors, diagnosed since 2010. It helps researchers understand these tumors better, which can guide future treatments.
This study tracks children and teens with certain rare blood cancers called myeloproliferative neoplasms (MPNs). By collecting information from many patients, doctors hope to better understand these conditions and improve care for young people.
This study is a registry, meaning it collects information from people diagnosed with malignant peripheral nerve sheath tumors (MPNST). It may help doctors learn about the condition better and improve future care.
This study keeps a careful record of children, teens, and young adults with cancer (and some related growths) and may follow them over time. It helps researchers better track outcomes and future contact so care can improve.
This study investigates Proteus syndrome, a rare condition that causes abnormal overgrowth of body parts, and related disorders. Researchers want to understand how these conditions develop, progress over time, and affect people of different ages—including how they may change into adulthood.
Hear when a new PTEN Hamartoma Tumor Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.